Quick Answer
Cingulate Inc. reported Research And Development Expense of $9.77 million for the year ending 2025.
- Cingulate Inc. showed an increase of +3.5% in Research And Development Expense from 2024 to 2025.
- This data is from Cingulate Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $562.5 thousand | Q2 2021: $793.6 thousand | Q3 2021: $5.79 million | Q1 2022: $2.76 million | Q2 2022: $2.18 million | Q3 2022: $2.12 million | Q1 2023: $2.13 million | Q2 2023: $4.46 million | Q3 2023: $3.92 million | Q1 2024: $1.81 million | Q2 2024: $1.88 million | Q3 2024: $1.43 million | Q1 2025: $2.22 million | Q2 2025: $2.70 million | Q3 2025: $2.85 million.
- Over the full 6 years of available data (2020 to 2025), Cingulate Inc.'s Research And Development Expense has grown by 91.9%.
- Historical annual values: Fiscal year 2025: $9.77 million | Fiscal year 2024: $9.45 million | Fiscal year 2023: $15.49 million | Fiscal year 2022: $9.00 million | Fiscal year 2021: $8.41 million | Fiscal year 2020: $5.09 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: